EGM
ADMS

Engineers Gate Manager’s Adamas Pharmaceuticals ADMS Stock Holding History

Engineers Gate Manager’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,434
Closed -$97K – 2127
2021
Q2 		$97K Buy
18,434
+2,439
+15% +$12.6K 0.01% 1500
2021
Q1 		$77K Buy
15,995
+4,754
+42% +$24.8K ﹤0.01% 1729
2020
Q4 		$49K Sell
11,241
-29,706
-73% -$127K ﹤0.01% 1634
2020
Q3 		$169K Buy
+40,947
New +$158K 0.01% 1465

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Engineers Gate Manager's ADMS Position: Q3 2021 in Review

Engineers Gate Manager sold out of Adamas Pharmaceuticals (ADMS) in Q3 2021, closing a stake of 18,434 shares — an estimated $97K sold.

Engineers Gate Manager first reported a position in ADMS in Q3 2020 and held it in 4 quarters. The position peaked at $169K in Q3 2020. 63 funds tracked by Wall St. Rank hold ADMS as of Q3 2021.

  • Engineers Gate Manager reported no remaining Adamas Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 18,434 Adamas Pharmaceuticals shares in Q3 2021, an estimated $97K.
  • Engineers Gate Manager first reported a position in Adamas Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Engineers Gate Manager's Adamas Pharmaceuticals position peaked at $169K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2021.

Based on Engineers Gate Manager's 13F filing for Q3 2021, filed 15 Nov 2021.